A. Maity et al., Low pO(2) and beta-estradiol induce VEGF in MCF-7 and MCF-7-5C cells: Relationship to in vivo hypoxia, BREAST CANC, 67(1), 2001, pp. 51-60
Previous work from this laboratory demonstrated that MCF-7 breast carcinoma
cells grown in nude mice contained minimal hypoxia but that tamoxifen trea
tment of these tumors resulted in increased hypoxia (Evans S. et al., Cance
r Research, 1997). These findings led to studies exploring the link between
estrogen signaling and tumor oxygenation and determining the role of VEGF
in this process. The stimulation of estrogen-dependent MCF-7 breast carcino
ma cells in vitro with beta -estradiol resulted in a two-fold induction of
VEGF mRNA and 1.3-2-fold increase in protein, similar to what was observed
when these cells were exposed to 0.1% oxygen. Furthermore, the two stimuli
given together had an additive effect on (increasing) VEGF expression, sugg
esting that the combination of hypoxia and estrogen may be important in upr
egulating VEGF in some breast cancers. Estrogen-independent MCF-7-5C cells,
developed by growing MCF-7 cells in long-term culture in estrogen-free med
ia, were also studied. Using EF5, a fluorinated 2-nitroimidazole which loca
lizes to hypoxic cells, MCF-7-5C tumors grown in nude mice were found to co
ntain lower pO(2) levels and more hypoxic regions than similarly grown MCF-
7 tumors. We tested the hypothesis that this might be the result of defecti
ve expression of VEGF in MCF-7-5C cells in response to beta -estradiol and/
or hypoxia. However, MCF-7-5C and MCF-7 cells showed a similar induction of
VEGF in vitro in response to either beta -estradiol or hypoxia. Therefore,
although these two cell lines grown as tumors have substantial differences
in the presence and patterns of hypoxia, this could not be explained by a
difference in VEGF induction.